Illness	Number of cases
Malignant neoplasm of bronchus and lung (C34.1)	186
Malignant neoplasm of bronchus and lung (C34.0)	141
Non-follicular lymphoma (C83.3)	80
Malignant neoplasm of bronchus and lung (C34.3)	68
Multiple myeloma and malignant plasma cell neoplasms - Multiple myeloma not having achieved remission (C90.00)	28
Malignant neoplasm of bronchus and lung (C34.8)	27
Malignant neoplasm without specification of site - Disseminated malignant neoplasm unspecified (C80.0)	24
Malignant neoplasm of breast (C50.9)	22
Malignant neoplasm of stomach - Malignant neoplasm of cardia (C16.0)	17
Malignant neoplasm of bronchus and lung - Malignant neoplasm of middle lobe bronchus or lung (C34.2)	16

Top 10 treatments

Treatment	Number
Cancer treatment for one or more days with chemotherapy drugs administered into a vein or beneath the skin (8-542.12)	376
Others therapeutic procedures to influence the immune system (8-547.0)	340
Computed tomography of the chest with contrast medium (3-222)	297
Computed tomography of the abdomen with contrast medium (3-225)	279
Cancer treatment for one or more days with chemotherapy drugs administered into a vein or beneath the skin (8-542.11)	257
Cancer treatment for several days (e.g. 2-4 days) with two or more chemotherapy drugs administered into a vein (8-543.13)	234
(9-984.7)	208
Computed tomography of the head with contrast medium (3-220)	182
Measurement of lung function in an airtight cabin - whole body plethysmography (1-710)	168
Transfusion of blood, red blood cells or platelets from a donor to a recipient (8-800.c0)	160

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 0500

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
71	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
57	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
50	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at universities of applied sciences
Project-related cooperation with colleges and universities
Student training (clinical traineeship / internship year)
Lectureships / teaching posts at colleges and universities

Training

No.	Training in other healing professions	Comment
HB19	Nursing professionals	Ausbildungsbeginn jährlich am 1. April und 1. September
HB07	Surgical technical assistant (m/f)	Ausbildungsbeginn jährlich am 1. April oder 1. September
HB15	Anaesthesia technical assistant (m/f)	Ausbildungsbeginn jährlich am 1. April